article · 2019
A phase II randomized, open-label study comparing salvage radiotherapy in combination with 6 months of androgen-deprivation therapy with LHRH agonist or antagonist versus anti-androgen therapy with apalutamide in patients with biochemical progression after radical prostatectomy
0 citationsDOI: https://doi.org/10.1093/annonc/mdz248.057Open accessPDF reported by metadata